Benutzer: Gast  Login
Titel:

[PSMA-targeted radioligand therapy in prostate cancer].

Dokumenttyp:
journal article
Autor(en):
Heck, M M; Retz, M; Tauber, R; Knorr, K; Kratochwil, C; Eiber, M
Abstract:
Radioligand therapy (RLT) directed against prostate-specific membrane antigen (PSMA) enables tumor-specific treatment directed against PSMA-overexpressing prostate cancer cells. Several PSMA ligands such as PSMA-617 or PSMA-I&T; have been developed that can be labeled with ?-radiating lutetium-177. These are currently applied in compassionate use programs to treat metastatic castration-resistant prostate cancer (mCRPC). PSMA-directed RLT is currently being offered in several nuclear medicine depar...     »
Zeitschriftentitel:
Urologe A
Jahr:
2017
Band / Volume:
56
Heft / Issue:
1
Seitenangaben Beitrag:
32-39
Sprache:
de
Volltext / DOI:
doi:10.1007/s00120-016-0274-3
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/27885457
Print-ISSN:
0340-2592
TUM Einrichtung:
Klinik und Poliklinik für Nuklearmedizin
 BibTeX